Call 08048980621 78% Response Rate

Send Enquiry

our range

Study on SURGISPON

Study on SURGISPON
This study aims to illustrate the impact of applying the tranexamic acid impregnated in a SURGOSPON between the anterior rectus sheath and the Rectus Abdominis muscle during Cesarean section (CS) in minimizing rectus sheath hematoma (RHS) in women treated with Warfarin.

Publication of Research Article in British Journal on Antibacterial activity of SURGI-ORC

Antibacterial activity of Surgi ORC® in Antibiotic Resistant Nosocomial pathogens in PSSSI – BJMR

CDSCO granted manufacturing license for Flowable Hemostatic Matrix - FLOGEL

Aegis Lifesciences is proud to get Manufacturing License for 1st of its kind Indigenous Flowable Hemostatic Matrix.
The product is well known for its excellent Hemostasis properties in critical surgeries and hard to reach Surgical bleeding site.
Till date product is being imported in India by top MNCs from USA.